Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M207Revenue (TTM) $M--Net Margin (%)--Altman Z-Score17.0
Enterprise Value $M80.9EPS (TTM) $-2.8Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.0Pre-tax Margin (%)--Higher ROA y-yN
Price/Book1.410-y EBITDA Growth Rate %--Quick Ratio23.8Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %7.4Current Ratio23.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-54.0Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-62.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M49.2ROIC % (ttm)-311.6Gross Margin Increase y-yN

Gurus Latest Trades with CASC

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

CASC is held by these investors:



CASC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Myers Scott DunsethPresident and CEO 2017-05-12Buy2,800$45view
Myers Scott DunsethPresident and CEO 2017-03-31Buy2,000$4.112.19view
Fyfe Gwen A.Director 2017-03-28Buy1,666$4.121.94view
Myers Scott DunsethPresident and CEO 2017-03-20Buy1,000$3.936.87view
LOVE TED WDirector 2017-02-02Buy23,000$4.24-0.94view
HENNEY CHRISTOPHER SDirector 2017-01-30Buy25,324$4.112.19view
Myers Scott DunsethPresident and CEO 2017-01-27Buy20,500$3.7611.7view
Myers Scott DunsethPresident and CEO 2016-08-17Buy7,500$6.9-39.13view
Myers Scott DunsethPresident and CEO 2016-06-28Buy10,417$4.8-12.5view
HAUSMAN DIANAChief Medical Officer 2015-06-01Buy5,747$4.65-9.68view

Press Releases about CASC :

Quarterly/Annual Reports about CASC:

    News about CASC:

    Articles On GuruFocus.com
    Cascadian Therapeutics Reports First Quarter 2017 Financial Results Conference Call Scheduled for To May 09 2017 
    Cascadian Therapeutics to Report First Quarter 2017 Financial Results on May 9, 2017 May 01 2017 
    Cascadian Therapeutics Highlights Preclinical Program Presentations at the American Association for Apr 05 2017 
    Cascadian Therapeutics Announces Changes to Board of Directors Mar 13 2017 
    Cascadian Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results Mar 09 2017 
    Seth Klarman Buys 25 Million Shares of Cascadian Therapeutics as Price Declines Jul 12 2016 
    Seth Klarman Buys 25 Million Shares of Cascadian Therapeutics Jul 11 2016 
    Value Betting with Special Situations: Lessons from the World of Gambling Mar 05 2013 
    Cubist Pharmaceutical - Acutely Aware May 09 2010 

    More From Other Websites
    Edited Transcript of CASC earnings conference call or presentation 9-May-17 12:30pm GMT May 12 2017
    Cascadian Therapeutics reports 1Q loss May 09 2017
    Investor Network: Cascadian Therapeutics Inc. to Host Earnings Call May 09 2017
    Cascadian Therapeutics Reports First Quarter 2017 Financial Results Conference Call Scheduled for... May 09 2017
    Cascadian Therapeutics to Report First Quarter 2017 Financial Results on May 9, 2017 May 01 2017
    Cascadian Therapeutics Highlights Preclinical Program Presentations at the American Association for... Apr 05 2017
    Cascadian Therapeutics Announces Changes to Board of Directors Mar 13 2017
    Cascadian Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results Mar 09 2017
    Should You Buy Alico, Inc. (ALCO)? Dec 20 2016
    Here’s What Smart Money Think about Jones Energy Inc (JONE) Dec 12 2016
    Do Hedge Funds Love Invuity, Inc. (IVTY)? Dec 10 2016
    Biotech Movers And Shakers: Cascadian Therapeutics Inc (USA) (CASC) And Anthera Pharmaceuticals Inc... Dec 08 2016
    Cascadian Therapeutics Enlarges Breast Cancer Pill Study to Meet FDA Registration Standards Dec 07 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)